Riskpilot← Back to searchSign inGet full accessBodyspaces IVS
IVSActiveCVR 37457469Skydebanegade 40, 4. thComputer programming activities · NACE 6210Est. 2016— employees
Revenue 2020
DKK -25K
+68% vs 2019
EBITDA margin
100.0%
-68% vs 2019
Equity ratio
45.8%
Financial strength
Net profit 2020
DKK -26K
-176% vs 2019
| Revenue | DKK -25K | +68% |
| EBITDA | DKK -25K | -68% |
| Net profit | DKK -26K | -176% |
| Total assets | DKK 11K | -64% |
| Equity | DKK 5K | -83% |
| Employees | — | — |
Legal name
Bodyspaces IVS
CVR number
37457469
Legal form
Iværksætterselskab
NACE code
6210 · Computer programming activities
Founded
13. februar 2016
Share capital
DKK 900
Employees
—
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Virksomhedens formål er udvikling og kommercialisering af it-løsninger indenfor sundheds- og behandlingsområdet.
Address
Skydebanegade 40, 4. th
Phone
+4539453950
Email
alr@accura.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 0 | -20 | -17 | -15 | -25 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 0 | -20 | -17 | -15 | -25 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 0 | -20 | -17 | -15 | -25 |
| Net financials | 0 | -12 | 45 | 49 | -1 |
| Profit before tax | 0 | -32 | 28 | 34 | -26 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | 0 | -32 | 28 | 34 | -26 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 1 | 64 | 46 | 31 | 11 |
| Equity | 1 | -31 | -3 | 31 | 5 |
| Long-term debt | 0 | 60 | 0 | 0 | 0 |
| Short-term debt | 0 | 35 | 49 | -0 | 6 |
| Total debt | 0 | 95 | 49 | -0 | 6 |
EBITDA margin
-2500000.0%
This company
15.8%
Market median
-15822885% vs market
20162020
Equity ratio
45.8%
This company
38.2%
Market median
+20% vs market
20162020
Return on equity
-502.6%
This company
18.4%
Market median
-2832% vs market
20162020
Net profit margin
-2605600.0%
This company
8.1%
Market median
-32168001% vs market
20162020
Asset turnover
-2.21×
This company
1.12×
Market median
-297% vs market
20162020
Debt / equity
1.18×
This company
0.62×
Market median
-90% vs market
20162020
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-02-13 – 2016-12-31
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
JP Founder | Founder | 2016 |
MK Founder | Founder | 2016 |
SA Unofficial title | Unofficial title | 2022 |
MC | Founder | 2016 |
ER Founder | Founder | 2016 |
| Former (1) | ||
FB Unofficial title | Unofficial title | 2019 – 2022 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50–66.65% | 50–66.65% | 2018 | |
| Individual | 20–24.99% | 20–24.99% | 2018 | |
| Individual | 15–19.99% | 20–24.99% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bodyspaces IVS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Pelle Marker | Founder | 0 companies |
| Mads Kristian Overgaard | Founder | 0 companies |
| Søren Aamann Jensen | Unofficial title | 0 companies |
| Frederik Bruhn | Unofficial title | 0 companies |
| Mattias Christoffer Leth-Hardrup | Founder | 0 companies |
| Elvi Rohde Nissen | Founder | 0 companies |